Claritas Pharmaceuticals, Inc.
CLAZF
Rank in Stocks
#34715
Operating as a clinical-stage specialty pharmaceutical entity, Claritas... Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$3.54K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Claritas Pharmaceuticals, Inc. (CLAZF)
Category
Healthcare
Operating Margin for Claritas Pharmaceuticals, Inc. (CLAZF)
Operating Margin as of November 2026 TTM: 0.00%
According to Claritas Pharmaceuticals, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2020 the company had an operating margin of 0.00%.
Operating Margin history for Claritas Pharmaceuticals, Inc. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | -100.00% |
| 2013 | -2,869.84% | 277.90% |
| 2012 | -759.42% | 59.18% |
| 2011 | -477.08% | -72.85% |
| 2010 | -1,757.06% | -99.04% |
| 2009 | -183,355.38% | 9,658.19% |
| 2008 | -1,878.99% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -181.36% | - |
US
|
|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Claritas Pharmaceuticals, Inc.'s operating margin
What was Claritas Pharmaceuticals, Inc.'s operating margin in 2020?
In 2020, Claritas Pharmaceuticals, Inc.'s operating margin was 0.00%, compared with 0.00% in 2019.
How has Claritas Pharmaceuticals, Inc.'s operating margin changed since 2015?
From 2015 to 2020, Claritas Pharmaceuticals, Inc.'s operating margin was highest in 2020 (0.00%) and lowest in 2020 (0.00%).
How does Claritas Pharmaceuticals, Inc.'s operating margin compare with similar companies?
Claritas Pharmaceuticals, Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.